alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# 6H

IN THE SUPREME COURT OF THE STATE OF MONTANA DA 21 - 0610 MARK DEMING, Plaint iff and Appellant

v. JASON DEMING and KELLY DEMING, Defendants and Appellee. ORDER OF MEDIATOR APPOINTMENT
This appeal being subject to M.R .App.P. 7, and the parti es having failed to j oint ly and timely select a mediator under M.R.App.P., 7(4),(c), IT IS ORDERED THAT **Elizabeth Mary**  **Varela,** whose name appears next on th e list of

attorneys desi

ring appo int me nta s me di ators fo r Mo ney Judgments a ppeals which is maintained pursuant to M.R.App.P., 7(4)(e), is hereby appo int ed to c onduct the mediat io n process required by M.R.App.P., 7(5), and IT IS FURTHER ORDERED th at th e time periods set fo rth in M.R.App.P., 7(5)(d) shall run from the date of th is order of appoint me nt . A true copy

of this order is being mailed to counsel of record f or the parti es, or to th e parties individually if not represented by counsel, on the date hereof. DATED thi s December 30, 2021.

Bowen Greenwood , Clerk of the Su preme Court c: Kevin J. Chapman, Penelope S. Strong, Elizabeth Mary Varela 12/30/2021

Case Number: DA 21-0610
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>  This schedule contains summary financial
information extracted from Balance Sheets and Statements of
Operations for the first quarter ended March 31, 1997 Form
10Q of Cinema Plus, L.P. and is qualified in its entirety by
reference to such financial statements.
       
<S>                                                 <C>
<PERIOD-TYPE>                                3-MOS
<FISCAL-YEAR-END>                      DEC-31-1997
<PERIOD-END>                           MAR-31-1997
<CASH>                                      896,000
<SECURITIES>                           2,227,000
<RECEIVABLES>                          23,229,000
<ALLOWANCES>                              0
<INVENTORY>                                 331,000
<CURRENT-ASSETS>                          0
<PP&E>                                    0
<DEPRECIATION>                            0
<TOTAL-ASSETS>                         26,683,000
<CURRENT-LIABILITIES>                     0
<BONDS>                                   0
<COMMON>                                  0
<PREFERRED-MANDATORY>                     0
<PREFERRED>                               0
<OTHER-SE>                             21,202,000
<TOTAL-LIABILITY-AND-EQUITY>           26,683,000
<SALES>                                   0
<TOTAL-REVENUES>                                  543,000
<CGS>                                     0
<TOTAL-COSTS>                               121,000
<OTHER-EXPENSES>                                    79,000
<LOSS-PROVISION>                          0
<INTEREST-EXPENSE>                                   41,000
<INCOME-PRETAX>                          302,000
<INCOME-TAX>                              0
<INCOME-CONTINUING>                           0
<DISCONTINUED>                            0
<EXTRAORDINARY>                           0
<CHANGES>                                 0
<NET-INCOME>                                      302,000
<EPS-PRIMARY>                                6.91
<EPS-DILUTED>                             0
        

</TABLE>
Exhibit 10.2
                                AMENDMENT TO THE
                           NAPRO BIOTHERAPEUTICS, INC.
                             1993 STOCK OPTION PLAN

         1.       Plan Sponsor:  NaPro BioTherapeutics, Inc.

         2.       Amendment of Plan:  The following  Amendment to the NaPro
BioTherapeutics,  Inc.  1993  Stock Option Plan (the "Plan") is adopted,
effective December 16, 2000:

         Section 9 of the Plan regarding Exercise Price and Consideration shall
         be amended by adding at the end thereof the following new subsection
         (e):

                  (e) Notwithstanding anything in the Plan to the contrary,
         effective December 16, 2000, unless approved by the holders of a
         majority of the shares present and entitled to vote at a duly convened
         meeting of the Company's shareholders, the Board shall not grant any
         Option with an exercise price that is less than 100% of the fair market
         value per Share on the date of grant or reduce the exercise price of
         any Option granted under the Plan.

         3.       Terms and Conditions of Plan.  Except for the above
amendments,  all terms and conditions of the Plan are unamended and shall remain
in full force and effect.

         4.       Execution.   The Plan sponsor  has executed this Amendment as
of the 11th day of December, 2000.

            NAPRO BIOTHERAPEUTICS, INC.
            Plan Sponsor
            By:      /s/ Gordon Link
                 -------------------------------

            Title:   VP, Chief Financial Officer
                  ------------------------------
* Pursuant to 5TH CIR. R. 47.5, the court has determined that

this opinion should not be published and is not precedent except

under the limited circumstances set forth in 5TH CIR. R. 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

February 7, 2007

Charles R. Fulbruge III

Clerk

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 06-50728

Conference Calendar

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

versus

JUAN CARLOS DURON-MORENO,

Defendant-Appellant.

--------------------

Appeal from the United States District Court

for the Western District of Texas 

USDC No. 3:05-CR-2704-ALL

--------------------

Before REAVLEY, JOLLY, and BENAVIDES, Circuit Judges.

PER CURIAM:*

Appealing the Judgment in a Criminal Case, Juan Carlos

Duron-Moreno raises arguments that are foreclosed by AlmendarezTorres v. United States, 523 U.S. 224, 235 (1998), which held

that 8 U.S.C. § 1326(b)(2) is a penalty provision and not a

separate criminal offense. The Government’s motion for summary

affirmance is GRANTED, and the judgment of the district court is

AFFIRMED.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS OF UTILX CORPORATION FOR THE NINE MONTHS ENDED
DECEMBER 31, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          MAR-31-1998
<PERIOD-END>                               DEC-31-1997
<CASH>                                             540
<SECURITIES>                                         0
<RECEIVABLES>                                   18,946
<ALLOWANCES>                                       435
<INVENTORY>                                      9,383
<CURRENT-ASSETS>                                28,995
<PP&E>                                          35,624
<DEPRECIATION>                                  24,829
<TOTAL-ASSETS>                                  40,382
<CURRENT-LIABILITIES>                           11,723
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            72
<OTHER-SE>                                      26,960
<TOTAL-LIABILITY-AND-EQUITY>                    40,382
<SALES>                                         62,078
<TOTAL-REVENUES>                                62,078
<CGS>                                           55,119
<TOTAL-COSTS>                                   61,584
<OTHER-EXPENSES>                                   326
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 299
<INCOME-PRETAX>                                    168
<INCOME-TAX>                                         1
<INCOME-CONTINUING>                                167
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       167
<EPS-PRIMARY>                                      .02
<EPS-DILUTED>                                      .02
        

</TABLE>
The District Court of the 18th Judicial District. County of Gallatin.

#### STATE OF MONTANA, Plaintiff, vs. TERRI LEE WARREN, Defendant.

CAUSE NO. DC-03-198 DECISION

On August 24, 2009, the defendant was sentenced for violation of the conditions of a suspended sentence to ten (10) years in the Montana State Prison, for the offense of Count I: Negligent Vehicular Assault, a felony.

On April 2, 2010, the defendant’s application for review of that sentence was heard by the Sentence Review Division of the Montana Supreme Court.

The defendant was present and was represented by Kris Copenhaver. The state was not represented.

Before hearing the application, the defendant was advised that the Sentence Review Division has the authority not only to reduce the sentence or affirm it, but also increase it. The defendant was fiirther advised that there is no appeal from a decision of the Sentence Review Division. The defendant acknowledged that she understood this and stated that she wished to proceed.

Rule 17 of the Rules of the Sentence Review Division of the Supreme Court of Montana provides that “the sentence imposed by the District Court is presumed correct, and the sentence will not be reduced or increased unless it is deemed clearly inadequate or excessive.” (§46-18-904(3), MCA).

The Division finds that the reasons advanced for modification are insufficient to hold that the sentence imposed by the District Court is inadequate or excessive.

Therefore, it is the unanimous decision of the Sentence Review Division that the sentence shall be affirmed.

Done in open Court this 2nd day of April, 2010.

DATED this 19th day of April, 2010.

Chairperson, Hon. Blair Jones, Member, Hon. Richard Simonton and Member, Hon. Ray Dayton.
exv4w3



 





Exhibit 4.3




AMENDMENT DEED




DATE 27 November 2007




PARTIES




Sims Group Limited ABN 69 114 838 630 (Sims)




Mitsui Raw Materials Development Pty Limited ACN 124 181 531 (Mitsui)




RECITAL



The parties wish to amend the Principal Document in the manner set out in this document.




OPERATIVE PROVISIONS





	1.	 	INTERPRETATION
	 
	1.1	 	Definitions
	 
	 	 	The following definitions apply in this document.
	 
	 	 	Principal Document means the Top-Up Deed dated 2 April 2007 between Sims and
Mitsui.
	 
	1.2	 	Terms used in Principal Document






	 	(a)	 	A term (other than a term defined in clause 1.1) that is defined in the Principal
Document (as amended by this document) has the same meaning in this document.
	 
	 	(b)	 	Clauses 1.2 and 3 of the Principal Document apply to this document.






	2.	 	AMENDMENT
	 
	2.1	 	Amendment to Principal Document
	 
	 	 	The Principal Document is amended as follows






	 	(a)	 	Insert a new clause 2.1 (a)(iii) as follows:






	 	2.1(a)(iii)	 	For the purposes of this clause 2, the Aggregate
Mitsui Group Shareholding shall be considered to be not less than 15%
 of the number of Shares on issue at the Relevant Time
if the Aggregate Mitsui Group Shareholding would have been
not less than 15% of the number of Shares on issue at the
Relevant Time but for any dilution as a result of any issue of Shares referred to in
sub-paragraphs (a)(i), (ii), (iii) and (iv) of the definition of
“Diluting Event” occurring within the 12 months preceding
the Relevant Time.






	 	(b)	 	In clause 2.3(a), delete the words “10 Business Days” and replace them
with “12 Business Days”.




 









 





	 	(c)	 	Delete clause 2.4(b) and replace it with the following new clause 2.4(b):






	 	2.4(b)	 	Top-Up Rights terminate
	 
	 	 	 	The Top-Up Rights terminate if at any time after commencement the
Aggregate Mitsui Group Shareholding is less than 15% of the
Shares on issue (“Termination Date”) unless the Aggregate Mitsui Group
Shareholding would have been not less than 15% of the
Shares on issue but for any dilution as a result of any issue of Shares
referred to in sub-paragraphs (a)(i), (ii), (iii) and (iv) of the
definition of “Diluting Event” occurring within the 12 months preceding the Termination Date.






	2.2	 	Effect of amendment






	 	(a)	 	Except as expressly amended by this document, the Principal Document is confirmed
and remains in full force and effect.
	 
	 	(b)	 	This document amends the Principal Document with effect from the date of the Principal
Document.
	 
	 	(c)	 	The Principal Document and this document will be read and construed as one document.





EXECUTED as a deed.




EXECUTED by Sims Group Limited:




	 	 	 	 	 
	/s/ Jeremy L. Sutcliffe
 

Signature of director

	 	 
	 	/s/ Frank Moratti
 

Signature of secretary
	 
	 	 	 	 
	Jeremy L. Sutcliffe

 

Name

	 	 	 	Frank Moratti

 

Name
	 
	 	 	 	 
	 
	 	 	 	 
	EXECUTED by Mitsui Raw Materials 

Development Pty Limited:
	 	 	 	 
	 
	 	 	 	 
	/s/ Stephen Menzies
 

Signature of director

	 	 	 	/s/ Ian Williams
 

Signature of director
	 
	 	 	 	 
	Stephen Menzies

 

Name

	 	 	 	Ian Williams

 

Name
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          MAR-31-1997
<PERIOD-START>                             APR-01-1996
<PERIOD-END>                               MAR-31-1997
<CASH>                                         142,124
<SECURITIES>                                         0
<RECEIVABLES>                                1,030,087
<ALLOWANCES>                                    31,000
<INVENTORY>                                  1,197,840
<CURRENT-ASSETS>                             2,364,490
<PP&E>                                         515,519
<DEPRECIATION>                                 334,413
<TOTAL-ASSETS>                               2,571,209
<CURRENT-LIABILITIES>                        1,162,125
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     1,379,778
<OTHER-SE>                                     (3,754)
<TOTAL-LIABILITY-AND-EQUITY>                 2,571,209
<SALES>                                      7,121,637
<TOTAL-REVENUES>                             7,139,752
<CGS>                                        5,453,597
<TOTAL-COSTS>                                6,785,318
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                31,000
<INTEREST-EXPENSE>                              96,320
<INCOME-PRETAX>                                258,114
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            258,114
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   258,114
<EPS-PRIMARY>                                      .16
<EPS-DILUTED>                                      .16
        

</TABLE>
<PAGE>

                                                                    Exhibit 99.2



Certification of Senior Vice President and CFO pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002

Laurel Capital Group, Inc.


In connection with the Annual Report of Laurel Capital Group, Inc. (the
"Company") on Form 10-K for the year ended June 30, 2002 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, John A.
Howard, Jr., Senior Vice President and Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

  1. The Report fully complies with the requirements of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

  2. The information contained in the Report fairly presents, in all material
     respects, the financial condition and results of operations of the Company
     as of and for the period covered by the Report.


/s/ John A. Howard, Jr.
-----------------------
John A. Howard, Jr.
Senior Vice President and Chief Financial Officer
September 30, 2002
<!DOCTYPE html>
<html>
<head>
    <meta name="viewport" content="width=device-width" />
    <meta name="robots" content="noindex">
    <title>Disclaimers - NIDDK</title>
    
<meta name="VIcurrentDateTime" content="638490787375854673" />
<meta name="VirtualFolder" content="/" />
<script type="text/javascript" src="/layouts/system/VisitorIdentification.js"></script>

</head>
<body>
    <div></div>
</body>
</html>
**Facebook****Email**Print**Facebook****Email

## Overview

#### Animal Resources Program Coordinator

Joseph Woo, M.S., M.B.A., LATG

wooj1@mail.nih.gov

The NIAMS Laboratory Animal Care and Use Section (LACU) provides support to all NIAMS Intramural Research Program (IRP) Branches and Laboratories. Our goal is to provide animal care and services that support research activities and further our understanding of musculoskeletal and skin diseases.

### Services

The LACU provides the following services to the NIAMS IRP:
                          - Veterinary care.
                          - Animal ordering.
                          - Assistance with protocol preparation.
                          - Training investigative staff in conducting animal procedures.
                          - Animal facility management - NIAMS ACRF.
                          - Monitoring animal health in shared and core facilities.
                          - Coordination of rodent rederivation.

#### Core Research Facilities

Labs at the NIAMS are supported by the following state-of-the-art facilities and services:
                                        - Biodata Mining and Discovery
                                        - Flow Cytometry
                                        - Genomic Technology
                                        - Laboratory Animal Care and Use
                                        - Light Imaging
                                        - Translational Immunology

## Staff

**Joseph Woo, M.S., M.B.A., LATG**

wooj1@mail.nih.gov

**Marcus Anderson**

marcus.anderson@nih.gov

**Rebecca Balcells**

rebecca.balcells@nih.gov

**Crystal Brobst-Wormell, D.V.M.**

brobstwc@mail.nih.gov

**Owen Cooper**

owen.cooper@nih.gov

**Dawit Deggfe **

deggfedt@mail.nih.gov 

**Alfonso Macias**

alfonso.macias@nih.gov

**Tiara McKinney**

Tiara.mckinney@nih.gov

## Image & Media Gallery

##### Laboratory Animal Care and Use

×

## News & Highlights

**Facebook****Email**Print**Facebook****Email
EXHIBIT 31. CERTIFICATION

I, William H. Campbell, Acting Chief Financial Officer , certify that:

     1. I have reviewed this quarterly report on Form 10-QSB of Earthworks
Entertainment, Inc.;

     2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this quarterly
report;

     3.Based on my  knowledge,  the  financial  statements  and other  financial
information  included in this  quarterly  report fairly  present in all material
respects the financial  condition,  results of operations  and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

     4. The  registrant's  other  certifying  officers and I are responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

         a) Designed  such  disclosure  controls and  procedures  to ensure that
material  information  relating to the  registrant,  including its  consolidated
subsidiaries, is made known to us by others within those entities,  particularly
during the period in which this quarterly report is being prepared;

         b) Evaluated the effectiveness of the registrant's  disclosure controls
and  procedures  as of a date  within 90 days prior to the  filing  date of this
quarterly report (the "Evaluation Date"); and

         c)  Presented  in this  quarterly  report  our  conclusions  about  the
effectiveness of the disclosure  controls and procedures based on our evaluation
as of the Evaluation Date;

     5. The registrant's other certifying  officers and I have disclosed,  based
on our most  recent  evaluation,  to the  registrant's  auditors  and the  audit
committee of the  registrant's  board of directors  (or persons  performing  the
equivalent functions):

         a) All significant  deficiencies in the design or operation of internal
controls  which  could  adversely  affect  the  registrant's  ability to record,
process,  summarize  and  report  financial  data  and have  identified  for the
registrant's auditors any material weaknesses in internal controls; and

         b) Any fraud,  whether or not  material,  that  involves  management or
other  employees  who  have a  significant  role  in the  registrant's  internal
controls; and

     6. The registrant's other certifying  officers and I have indicated in this
quarterly  report  whether or not there  were  significant  changes in  internal
controls or in other factors that could  significantly  affect internal controls
subsequent to the date of our most recent  evaluation,  including any corrective
actions with regard to significant deficiencies and material weaknesses.

Dated: May 14, 2004    /s/ WILLIAM H. CAMPBELL
                        -----------------------
                        William H. Campbell
                        Chief Financial Officer
Exhibit 10.11

                                    AMENDMENT
                                       TO
                                MASTER AGREEMENT
                       FOR SALE AND PURCHASE OF MORTGAGES


         This amendment is entered into by and between Bay Financial Savings
Bank, F.S.B. ("Buyer") and Westmark Mortgage Corporation ("Seller") on the 12th
day of February, 1999. The parties mutually agree to amend that certain Master
Agreement for Sale and Purchase of Mortgages entered into by and between the
parties hereto as follows:

1.       V, (B), 1: The second sentence is hereby amended to read as follows:
                  "The Seller has not sold, assigned or otherwise transferred
                  any right or interest in or to the loan and has not pledged
                  the loan as collateral for any loan or obligation of Seller or
                  other purpose, save and except for any right, interest or
                  claim of Seller's warehouse lenders."

2.       V, 03), 14, 22 and 23: Each are hereby amended and modified to limit
         the representations and warranties contained in paragraphs 14, 2:2 and
         :23 "to Seller's knowledge."

3.       V, (B), 21 and VI (G): Each are hereby amended to increase the
         appraisal discrepancy from 9%.

4.       VI: "Breach of Representations and Warranties" is hereby amended and
         modified to provide Seller with the right to cure the breach of any
         representation or warranty contained in V, (B), 1, 5,6, 7, 9, 10, 11,
         12, 13, 15, 18, 24, and 25, within thirty (30) days from the date
         notice to cure is received by Seller.

5.       VIII: "Identification" is hereby amended to read "Indemnification."

6.       Except as hereinabove amended or modified, said Master Agreement for
         Sale and Purchase of Mortgages shall continue in full force and effect.

BAY FINANCIAL SAVINGS BANK, F.S.B.          WESTMARK MORTGAGE CORPORATION


By:                                        By: /s/ Payton Story, III
   ------------------------------             ---------------------------------
Its:                                       Its:  President
    -----------------------------              --------------------------------